Drug intelligence / Profile preview

[18F]-FMH3

Development stage
Phase 1
Lead developer
Institute for Neurodegenerative Disorders
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

[18F]-FMH3 is a diagnostic radiopharmaceutical developed as a highly specific positron emission tomography (PET) imaging biomarker for the histamine H3 receptor. It is used in research to visualize and quantify H3 receptor activity in the brain, particularly for studies related to neurodegenerative diseases such as Alzheimer's disease. The mechanism of action involves acting as a PET tracer that binds selectively to the histamine H3 receptor, allowing non-invasive imaging of its distribution and occupancy in vivo. Initial development was by the Institute for Neurodegenerative Disorders, with early clinical studies demonstrating promising brain uptake and specificity for H3 receptors in both human and non-human primates[1][2].

Other names
[18F]FMH3
02

Targets

HRH3 (Histamine Receptor H3)

Beyond the preview

Go deeper on [18F]-FMH3.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on [18F]-FMH3.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call